# Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

Study · id `cardio:ct-nct02770664` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02770664](<https://clinicaltrials.gov/study/NCT02770664>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02770664

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02770664. Randomized; double masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2018-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02770664, source copy `cardio:ctgov-nct02770664-2016-05-12`, retrieved 2026-10-26)
- Start date: 2016-04 (registry gives no type) (ClinicalTrials.gov record NCT02770664, source copy `cardio:ctgov-nct02770664-2016-05-12`, retrieved 2026-10-26)
- Primary completion: 2018-08 (anticipated) (ClinicalTrials.gov record NCT02770664, source copy `cardio:ctgov-nct02770664-2016-05-12`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: South Korea (ClinicalTrials.gov record NCT02770664, source copy `cardio:ctgov-nct02770664-2016-05-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02770664-2016-05-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
- Condition: ST-segment Elevation Myocardial Infarction
- Intervention (Drug): Placebo
- Intervention (Drug): LC28-0126 Dose A
- Intervention (Drug): LC28-0126 Dose B
- Intervention (Drug): LC28-0126 Dose C
- Lead sponsor: LG Life Sciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: LG Life Sciences (`cardio:org-lg-life-sciences`)

## Provenance

Content hash: 6c06622b8498ce4e2e7f0372daf97b2e0657c6ae8f0fa9e849250765b0848ef3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
